Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study—The ARTHR-IS Study Group

Introduction Guidelines have improved the management of prosthetic joint infections (PJI). However, it is necessary to reassess the incidence and risk factors for treatment failure (TF) of Staphylococcus aureus PJI (SA-PJI) including functional loss, which has so far been neglected as an outcome. Methods A retrospective cohort study of SA-PJI was performed in 19 European hospitals between 2014 and 2016. The outcome variable was TF, including related mortality, clinical failure and functional loss both after the initial surgical procedure and after all procedures at 18 months. Predictors of TF were identified by logistic regression. Landmark analysis was used to avoid immortal time bias with rifampicin when debridement, antibiotics and implant retention (DAIR) was performed. Results One hundred twenty cases of SA-PJI were included. TF rates after the first and all surgical procedures performed were 32.8% and 24.2%, respectively. After all procedures, functional loss was 6.0% for DAIR and 17.2% for prosthesis removal. Variables independently associated with TF for the first procedure were Charlson ≥ 2, haemoglobin < 10 g/dL, bacteraemia, polymicrobial infection and additional debridement(s). For DAIR, TF was also associated with a body mass index (BMI) > 30 kg/$ m^{2} $ and delay of DAIR, while rifampicin use was protective. For all procedures, the variables associated with TF were haemoglobin < 10 g/dL, hip fracture and additional joint surgery not related to persistent infection. Conclusions TF remains common in SA-PJI. Functional loss accounted for a substantial proportion of treatment failures, particularly after prosthesis removal. Use of rifampicin after DAIR was associated with a protective effect. Among the risk factors identified, anaemia and obesity have not frequently been reported in previous studies. Trial registration This study is registered at clinicaltrials.gov, registration no. NCT03826108. Graphical abstract.

Plain Language Summary Staphylococcus aureus is one of the most virulent bacteria and frequently causes prosthetic joint infections. Knowledge of the treatment of this type of infection has advanced in recent years, and treatment guidelines have led to improved management. Typically, the successful treatment of these infections has been determined by clinical cure, that is, the symptoms of infection have disappeared, but has not taken into account loss of function (such as significant difficulties walking), which is critical for the patient’s quality of life. Our aim in this study was to evaluate the success of current management strategies for S. aureus prosthetic joint infection, including recovery of functionality, and the factors that predict why some of these infections are not cured, to identify areas for improvement. In a multinational cohort of 128 patients with S. aureus prosthetic joint infection, rates of treatment failure were found to be high, with significant rates of loss of function, especially when the prosthesis needed to be removed. Loss of function was less frequent when the infection was initially treated with surgical cleaning without removal of the prosthesis, even when this procedure failed at first. We found that anaemia and obesity were associated with lower treatment success, and that the probability of treatment success increased when surgical cleaning without prosthesis removal was performed early, and when the antibiotic rifampicin was used in combination with another antibiotic..

Medienart:	E-Artikel

Erscheinungsjahr:	2022
Erschienen:	2022

Enthalten in:	Zur Gesamtaufnahme - volume:11
Enthalten in:	Infectious diseases and therapy - 11(2022), 6 vom: 15. Okt., Seite 2177-2203

Sprache:	Englisch

Beteiligte Personen:

Espíndola, Reinaldo [VerfasserIn] Vella, Venanzio [VerfasserIn] Benito, Natividad [VerfasserIn] Mur, Isabel [VerfasserIn] Tedeschi, Sara [VerfasserIn] Zamparini, Eleonora [VerfasserIn] Hendriks, Johannes G. E. [VerfasserIn] Sorlí, Luisa [VerfasserIn] Murillo, Oscar [VerfasserIn] Soldevila, Laura [VerfasserIn] Scarborough, Mathew [VerfasserIn] Scarborough, Claire [VerfasserIn] Kluytmans, Jan [VerfasserIn] Ferrari, Mateo Carlo [VerfasserIn] Pletz, Mathias W. [VerfasserIn] Mcnamara, Iain [VerfasserIn] Escudero-Sanchez, Rosa [VerfasserIn] Arvieux, Cedric [VerfasserIn] Batailler, Cecile [VerfasserIn] Dauchy, Frédéric-Antoine [VerfasserIn] Liu, Wai-Yan [VerfasserIn] Lora-Tamayo, Jaime [VerfasserIn] Praena, Julia [VerfasserIn] Ustianowski, Andrew [VerfasserIn] Cinconze, Elisa [VerfasserIn] Pellegrini, Michele [VerfasserIn] Bagnoli, Fabio [VerfasserIn] Rodríguez-Baño, Jesús [VerfasserIn] del Toro, Maria Dolores [VerfasserIn]

Links:	Volltext [kostenfrei]

Themen:	Clinical failure Functional failure Outcome Prosthetic joint infection

Anmerkungen:	© The Author(s) 2022

doi:	10.1007/s40121-022-00701-0

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC2132762171